Stanford University

Total Awards: 
131
Award Value: 
$359,981,601
Major Facility Name: 
Lorry I. Lokey Stem Cell Research Building
Institution type: 
Not for profit

Short Name: 
Stanford

Awards to the Institution

Program Investigator Award Title Award Value
SEED Grant Susan McConnell Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease $607,363
Late Stage Preclinical Projects Gary Steinberg Intraparenchymal NR1 Stem Cell Therapy for Chronic Subcortical Ischemic Stroke $5,300,000
Research Training II Theo Palmer Stanford CIRM Training Program $7,017,629
Genomics Centers of Excellence Awards (R) Michael Snyder Center of Excellence for Stem Cell Genomics - Stanford $22,796,609
Inception - Discovery Stage Research Projects Jeffrey Goldberg Embryonic Stem Cells for Corneal Endothelial Degeneration $235,836
Tools and Technologies I Helen Blau Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells $949,608
Basic Biology IV Anne Brunet Energy metabolism and aging pathways in human stem cell reprogramming and differentiation $1,414,044
Basic Biology II Garry Nolan Kinase signaling analysis of iPS cell reprogramming and differentiation $1,343,100
SEED Grant Aaron Hsueh Patient-specific cells with nuclear transfer $629,653
Tool Translational Research Projects Joseph Wu A Novel, Robust and Comprehensive Predictive Tool Using Human Disease-Specific Induced Pluripotent Stem Cells for Preclinical Drug Screening $1,000,000
Tools and Technologies II Irving Weissman Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,814
Basic Biology V Helen Blau Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
SPARK Paul Utz Stem Cell and Regenerative Medicine- Summer Research Internship $392,975
Comprehensive Grant Julie Baker Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cells $2,518,303
Quest - Discovery Stage Research Projects Irving Weissman Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells $1,968,456
Early Translational III Bertha Chen Autologous iPSC Therapy for Urinary Incontinence $4,715,738
New Cell Lines Michele Calos Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses $1,406,875
Conference Fan Yang 2014 Materials Research Society (MRS) Spring Meeting: Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions $10,000
New Faculty I Karl Deisseroth Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
Tissue Collection for Disease Modeling Joachim Hallmayer Induced pluripotent stem cells from children with autism spectrum disorders $530,265
SEED Grant Mark Kay Novel vectors for gene transfer into human ES cells $574,737
Disease Team Planning Thomas Rando Stem Cell Therapy for Muscular Dystrophy $0
Disease Team Therapy Planning I Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
Tools and Technologies III Anthony Oro A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability $1,391,125
Quest - Discovery Stage Research Projects Hiromitsu Nakauchi Novel Rejuvenated T Cell Immunotherapy for Lung Cancer $1,968,456
Transplantation Immunology Christopher Contag Engineering Embryonic Stem Cell Allografts for Operational Tolerance $1,411,338
Basic Biology IV Michael Cleary Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells $1,244,455
Basic Biology II Aaron Hsueh Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation $1,309,018
SEED Grant Thomas Wandless Reprogramming Differentiated Human Cells to a Pluripotent State $380,005
Conference II Joseph Wu 2017 Stanford Drug Discovery and Stem Cell Technology Conference $2,359
Tools and Technologies II Marius Wernig Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
Basic Biology V Marius Wernig Mechanisms of human induced neuronal cell reprogramming $1,178,370
Therapeutic Translational Research Projects Albert Wong 2nd Generation Vaccine for the Treatment of Glioblastoma $2,929,889
Comprehensive Grant Theo Palmer Immunology of neural stem cell fate and function $2,396,000
Conference II Joseph Wu 2018 Stanford Drug Discovery and Stem Cell Technology Conference $15,000
Disease Team Therapy Development - Research Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $19,068,382
New Cell Lines Michael Longaker Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts $1,406,636
Conference Joseph Wu Cardiovascular Regenerative Medicine Symposium $9,000
New Faculty I Joanna Wysocka Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,373,903
Tissue Collection for Disease Modeling Joseph Wu Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,291,832
SEED Grant Julien Sage Functions of RB family proteins in human embryonic stem cells $498,609
Late Stage Preclinical Projects Matthew Porteus Genome Editing of Autologous Hematopoietic Stem Cells to Treat Sickle Cell Disease $4,849,363
Disease Team Therapy Planning I Albert Wong Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Tools and Technologies III Fan Yang Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival $1,438,200
Quest - Discovery Stage Research Projects Rosa Bacchetta GENE EDITING FOR FOXP3 IN HUMAN HSC $984,228
Transplantation Immunology Robert Negrin Regulatory T cell induced tolerance to ESC transplantation $1,382,658
Basic Biology IV Alexander Dunn Role of mechanical signaling in stem cell self-renewal and differentiation $1,062,998
Early Translational II Michele Calos Stem Cell Therapy for Duchenne Muscular Dystrophy $2,267,261
SEED Grant Kenneth Weinberg Embryonic stem cell-derived thymic epithelial cells $628,793
Patent Assistance Fund Awards Katharine Ku Funding for Patent Applications for CIRM-funded Inventions out of Stanford University $3,525
Basic Biology III Michael Clarke USP16 controls stem cell number: implications for Down Syndrome $1,263,826
Basic Biology V Gary Steinberg Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
Conference II Joseph Wu Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
Comprehensive Grant Christopher Zarins Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells $2,454,490
Tools and Technologies III James Dunn Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $773,327
Disease Team Therapy Development - Research Joseph Wu Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,060,330
Basic Biology I Susan McConnell Identification and characterization of human ES-derived DA neuronal subtypes $1,404,853
New Cell Lines Theo Palmer Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype $1,409,243
Conference Thomas Rando Keystone Symposia, 'The Life of a Stem Cell: From Birth to Death' $50,000
Tools and Technologies II Michele Calos Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
Early Translational IV Michele Calos Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
Tools and Technologies III Sarah Heilshorn Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System $1,347,767
New Faculty II Ching-Pin Chang VEGF signaling in adventitial stem cells in vascular physiology and disease $3,005,695
Therapeutic Translational Research Projects Anthony Oro DEBCT: Genetically Corrected, Induced Pluripotent Cell-Derived Epithelial Sheets for Definitive Treatment of Dystrophic Epidermolysis Bullosa $5,107,353
Disease Team Therapy Planning I Robert Robbins Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
Quest - Discovery Stage Research Projects Roel Nusse Preclinical development of human hepatocyte progenitor cells for cell therapy $1,651,643
Transplantation Immunology Judith Shizuru Purified allogeneic hematopoietic stem cells as a platform for tolerance induction $1,233,275
Basic Biology IV Michelle Monje Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain $1,264,248
Disease Team Research I Alfred Lane iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa $11,039,208
SEED Grant Joseph Wu In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity $623,634
Inception - Discovery Stage Research Projects Helen Blau Prodrug innovation to target muscle stem cells and enhance muscle regeneration $235,834
Basic Biology III Aaron Hsueh Correlated time-lapse imaging and single cell molecular analysis of human embryo development $1,259,733
Major Facilities John Hennessy Stanford SIM1 Building $43,578,000
Inception - Discovery Stage Research Projects Phillip Yang Activation of patient-specific endogenous myocardial repair through the exosomes generated from the hypoxic iPSC-derived cardiomyocytes (iCMs). $234,619
Comprehensive Grant Theo Palmer Human oocyte development for genetic, pharmacological and reprogramming applications $2,298,411
Clinical Trial Stage Projects Crystal Mackall Phase 1 Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults with Recurrent or Refractory B Cell Malignancies $11,034,982
Basic Biology IV Howard Chang Long noncoding RNAs for pluripotency and cell fate commitment $1,386,627
Basic Biology I Julien Sage The retinoblastoma (RB) gene family in cellular reprogramming $1,357,085
SEED Grant Krishna Shenoy Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium $572,891
Conference Hank Greely Stem Cell Policy: Understanding the Scientific and Legal Challenges Ahead $5,838
Tools and Technologies II Theo Palmer Development of small molecule screens for autism using patient-derived iPS cells $1,797,606
Disease Team Therapy Development III Irving Weissman Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $6,505,568
Tools and Technologies III Irving Weissman Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp... $1,271,952
Comprehensive Grant Irving Weissman Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells $2,471,386
Inception - Discovery Stage Research Projects Guillem Pratx Novel metabolic labeling method for tracking stem cells to irradiated salivary glands using PET $235,613
Training Grant I-1 Michael Longaker Stanford CIRM Training Program $3,035,282
Quest - Discovery Stage Research Projects Matthew Porteus Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells $1,968,456
Transplantation Immunology Kenneth Weinberg Engineered immune tolerance by Stem Cell-derived thymic regeneration $1,271,729
Creativity Awards Paul Utz SIMR Program: Stem Cell & Developmental Biology Research Internships $340,611
Disease Team Research I Gary Steinberg Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke $17,244,851
SEED Grant Joanna Wysocka Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency $629,952
Quest - Discovery Stage Research Projects Mark Mercola Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI $1,809,234
Basic Biology III Joanna Wysocka Enhancer-mediated gene regulation during early human embryonic development $1,420,618
Disease Team Planning Robert Robbins {REDACTED} Cardiovascular Regenerative Team $25,119
Inception - Discovery Stage Research Projects Bertha Chen Autologous iPSC-based therapy for radiation induced bladder injury $235,836
Early Translational I Jill Helms Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Therapeutic Translational Research Projects Bertha Chen Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence $5,997,155
Basic Biology IV Gerald Crabtree Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch $1,392,150
Basic Biology I Helen Blau Molecular Mechanisms of Reprogramming towards Pluripotency $1,408,332
SEED Grant Calvin Kuo Differentiation of Human Embryonic Stem Cells to Intestinal Fates $554,176
Conference Joseph Wu Cardiovascular Tissue Engineering Symposium $25,000
Tools and Technologies II Sarah Heilshorn Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $600,695
Research Leadership Hiromitsu Nakauchi Generation of functional cells and organs from iPSCs $5,427,512
Tools and Technologies III Joseph Wu Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts $1,689,744
Comprehensive Grant Stefan Heller Generation of inner ear sensory cells from human ES cells toward a cure for deafness $2,330,371
Inception - Discovery Stage Research Projects Hiromitsu Nakauchi Optimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion $210,906
Early Translational III Joseph Wu Heart Repair with Human Tissue Engineered Myocardium $4,396,738
Disease Team Research I Irving Weissman Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $18,759,276
Conference Julien Sage 3rd International RB conference $10,000
New Faculty I Anne Brunet Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
New Faculty Physician Scientist Alan Cheng Enhancing hair cell regeneration in mouse and human inner ear $3,091,595
SEED Grant Phillip Yang In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction $629,952
Conference II Samuel Strober Third International Workshop on Clinical Tolerance $29,500
Basic Biology III Sean Wu Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells $1,260,537
Shared Labs Theo Palmer The Stanford University Center for Human Embryonic Stem Cell Research and Education $2,439,590
Inception - Discovery Stage Research Projects Philip Beachy Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells $210,906
Shared Labs Vittorio Sebastiano The Stanford University Center for Human Embryonic Stem Cell Research and Education $3,434,600
Quest - Discovery Stage Research Projects Vittorio Sebastiano Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome $865,282
Basic Biology IV Roel Nusse Asymmetric stem cell division oriented by a local self-renewing signal $1,039,058
Basic Biology II Steven Artandi Self-renewal and senescence in iPS cells derived from patients with a stem cell disease $931,285
SEED Grant John Cooke EC regeneration in cerebrovascular ischemia: role of NO $476,995
Clinical Trial Stage Projects Samuel Strober Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors $6,653,266
Tools and Technologies II Brian Rutt Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Basic Biology V Xinnan Wang Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
Preclinical Development Awards Matthew Porteus Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1 $874,877
Comprehensive Grant Roel Nusse Guiding the developmental program of human embryonic stem cells by isolated Wnt factors $1,710,462
Quest - Discovery Stage Research Projects Helen Blau Stimulating endogenous muscle stem cells to counter muscle atrophy $2,198,687
Early Translational III Helen Blau Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,920
New Cell Lines Julie Baker Derivation of hESC Lines with Disease Lesions $1,404,725
Conference Thomas Rando Third Annual Symposium on Regenerative Rehabilitation $20,000
New Faculty I Howard Chang Noncoding RNAs in Cell Fate Determination $2,985,894
New Faculty Physician Scientist Michelle Monje White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,800,536
Total:
$359,981,602.00
Icon for xls export